- Conditions
- Respiratory Distress Syndrome in Premature Infant
- Interventions
- AeroFact, nCPAP
- Drug · Other
- Lead sponsor
- Aerogen Pharma Limited
- Industry
- Eligibility
- 26 Weeks to 31 Weeks
- Enrollment
- 261 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 37
- States / cities
- Little Rock, Arkansas • Berkeley, California • Orange, California + 27 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 57
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Bronchopulmonary Dysplasia
- Interventions
- Exosurf, Survanta
- Drug
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- Up to 6 Hours
- Enrollment
- 617 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1991 – 1992
- U.S. locations
- 13
- States / cities
- Palo Alto, California • New Haven, Connecticut • Washington D.C., District of Columbia + 10 more
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- IV Atropine and Fentanyl Premedication Arm, IV Normal Saline Placebo Arm
- Drug
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Eligibility
- 0 Hours to 72 Hours
- Enrollment
- 58 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Neonatal Respiratory Distress Related Conditions, Meconium, Perinatal Morbidity, Neonatal Acidosis, Cord Blood, Neonatal Brain Injury, Maternal Morbidity, Mechanical Ventilation, CPAP, Surfactant, Perinatal Death, Amnioinfusion, NICU Admission
- Interventions
- Intrauterine pressure catheter, Standard obstetric care at discretion of delivery provider
- Device · Other
- Lead sponsor
- Medical College of Wisconsin
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 320 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Milwaukee, Wisconsin
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- PS Group, NCPAP Group, ISX Group
- Drug · Device
- Lead sponsor
- Vermont Oxford Network
- Network
- Eligibility
- 26 Weeks to 29 Weeks
- Enrollment
- 648 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2011
- U.S. locations
- 1
- States / cities
- Burlington, Vermont
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- CUROSURF® (poractant alfa)
- Drug
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Respiratory Distress Syndrome
- Interventions
- Nasal continuous positive airway pressure (nCPAP), Laryngeal Mask Airway (LMA) to deliver surfactant, Surfactants, Pulmonary
- Device · Drug
- Lead sponsor
- University of Minnesota
- Other
- Eligibility
- Up to 36 Hours
- Enrollment
- 103 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 7
- States / cities
- Loma Linda, California • San Diego, California • Maple Grove, Minnesota + 4 more
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- Endotracheal intubation, Laryngeal mask airway, remifentanil
- Device · Drug
- Lead sponsor
- Albany Medical College
- Other
- Eligibility
- 2 Hours to 48 Hours
- Enrollment
- 93 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2020
- U.S. locations
- 1
- States / cities
- Albany, New York
- Conditions
- Respiratory Distress Syndrome, Newborn, Premature Birth, Bronchopulmonary Dysplasia
- Interventions
- Lucinactant 175 mg/kg, Lucinactant 90 mg/kg, Placebo
- Drug
- Lead sponsor
- Windtree Therapeutics
- Industry
- Eligibility
- 3 Days to 10 Days
- Enrollment
- 136 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Warrington, Pennsylvania
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- A.1 Lucinactant, B.3 SoC, A.2 Lucinactant, A.3 Lucinactant, A.4 Lucinactant, B.1 Lucinactant, B.2 Lucinactant
- Drug · Other
- Lead sponsor
- Windtree Therapeutics
- Industry
- Eligibility
- 16 Years to 75 Years
- Enrollment
- 124 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2001 – 2006
- U.S. locations
- 1
- States / cities
- Warrington, Pennsylvania
- Conditions
- Neonatal Respiratory Distress
- Interventions
- Infasurf Aero
- Combination Product
- Lead sponsor
- ONY
- Industry
- Eligibility
- Up to 42 Weeks
- U.S. locations
- 5
- States / cities
- Jackson, Mississippi • Buffalo, New York • Greenville, North Carolina + 2 more
- Conditions
- Dermatitis, Atopic, Rosacea, Acne Vulgaris, Sensitive Skin
- Interventions
- Non-marketed Cosmetic Facial Cleanser
- Other
- Lead sponsor
- Johnson & Johnson Consumer Inc. (J&JCI)
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 85 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- High Point, North Carolina
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- Surfactant
- Drug
- Lead sponsor
- Sood, Beena G., MD, MS
- Individual
- Eligibility
- Up to 24 Hours
- Enrollment
- 159 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2020
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction), Bronchopulmonary Dysplasia
- Interventions
- Infasurf (ONY Inc.), Sham
- Drug
- Lead sponsor
- Roberta Ballard
- Other
- Eligibility
- 7 Days to 14 Days
- Enrollment
- 85 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 9
- States / cities
- Berkeley, California • Oakland, California • San Francisco, California + 5 more
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- AT-100, Air-sham
- Biological · Procedure
- Lead sponsor
- Airway Therapeutics, Inc.
- Industry
- Eligibility
- 0 Minutes to 96 Hours
- Enrollment
- 37 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 9
- States / cities
- Tucson, Arizona • Little Rock, Arkansas • Los Angeles, California + 6 more
- Conditions
- Superficial Bladder Cancer, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Non-muscle Invasive Bladder Cancer
- Interventions
- EG-70 (phase 1), EG-70 (phase 2) Master Protocol, Surfactant Bladder Pre-Rinse and EG-70 (Substudy)
- Drug
- Lead sponsor
- enGene, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 350 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2030
- U.S. locations
- 50
- States / cities
- Birmingham, Alabama • Scottsdale, Arizona • Tucson, Arizona + 43 more
- Conditions
- Burns
- Interventions
- Surfactant Gel
- Device
- Lead sponsor
- Medline Industries
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020
- U.S. locations
- 2
- States / cities
- Maywood, Illinois • Baton Rouge, Louisiana
- Conditions
- Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Bronchopulmonary Dysplasia, Continuous Positive Airway Pressure
- Interventions
- CPAP/PEEP, Standard management practices
- Device
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- Up to 10 Minutes
- Enrollment
- 104 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2003
- U.S. locations
- 6
- States / cities
- Birmingham, Alabama • San Diego, California • Miami, Florida + 3 more
- Conditions
- Infant, Extremely Premature, Acute Lung Injury, Chronic Lung Disease of Prematurity, Budesonide
- Interventions
- Infants in the study group (S/B group) will receive surfactant 2.5 mls/kg and Budesonide 0.5 mg (1mL), Infants in the control group (S/P group) receive placebo (Normal saline 1mL)
- Drug
- Lead sponsor
- University of Arizona
- Other
- Eligibility
- Up to 18 Hours
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 1
- States / cities
- Tucson, Arizona
- Conditions
- Bronchopulmonary Dysplasia (BPD), Respiratory Distress Syndrome, Prematurity; Extreme, Neonatal
- Interventions
- budesonide (Pulmicort nebulizing suspension)., surfactant (poractant alfa;Curosurf)
- Drug
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- Up to 48 Hours
- Enrollment
- 642 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2026
- U.S. locations
- 19
- States / cities
- Birmingham, Alabama • Palo Alto, California • San Diego, California + 15 more
- Conditions
- Prematurity, Respiratory Distress Syndrome, Patent Ductus Arteriosus
- Interventions
- Survanta (beractant), Curosurf (poractant)
- Drug
- Lead sponsor
- Alan Fujii
- Other
- Eligibility
- Up to 8 Hours
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Infasurf, Pulmicort, Sham
- Drug · Other
- Lead sponsor
- East Carolina University
- Other
- Eligibility
- 24 Weeks to 28 Weeks
- Enrollment
- 45 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Greenville, North Carolina
- Conditions
- Respiratory Distress Syndrome
- Interventions
- Poractant alfa, calfactant
- Drug
- Lead sponsor
- University of Missouri-Columbia
- Other
- Eligibility
- 22 Weeks to 35 Weeks
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Columbia, Missouri
- Conditions
- Respiratory Distress Syndrome, Newborn, Premature Birth
- Interventions
- Poractant Alfa
- Drug
- Lead sponsor
- Endeavor Health
- Other
- Eligibility
- Up to 15 Minutes
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Evanston, Illinois